These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9296325)

  • 1. Evening dosing is associated with higher plasma concentrations of pranlukast, a leukotriene receptor antagonist, in healthy male volunteers.
    Brocks DR; Upward J; Davy M; Howland K; Compton C; McHugh C; Dennis MJ
    Br J Clin Pharmacol; 1997 Sep; 44(3):289-91. PubMed ID: 9296325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The single and multiple dose pharmacokinetics of pranlukast in healthy volunteers.
    Brocks DR; Upward JW; Georgiou P; Stelman G; Doyle E; Allen E; Wyld P; Dennis MJ
    Eur J Clin Pharmacol; 1996; 51(3-4):303-8. PubMed ID: 9010703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pranlukast: a review of its use in the management of asthma.
    Keam SJ; Lyseng-Williamson KA; Goa KL
    Drugs; 2003; 63(10):991-1019. PubMed ID: 12699401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers.
    O'Shaughnessy TC; Georgiou P; Howland K; Dennis M; Compton CH; Barnes NC
    Thorax; 1997 Jun; 52(6):519-22. PubMed ID: 9227717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morning-evening administration time differences in digoxin kinetics in healthy young subjects.
    Erol K; Kiliç FS; Batu OS; Yildirim E
    Chronobiol Int; 2001 Sep; 18(5):841-9. PubMed ID: 11763991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma.
    Barnes NC; Pujet JC
    Thorax; 1997 Jun; 52(6):523-7. PubMed ID: 9227718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of pranlukast in healthy young and elderly subjects.
    Brocks DR; Upward J; Hust R; Köester FE; Collie H; Qian Y; Dennis MJ
    Int J Clin Pharmacol Ther; 1996 Sep; 34(9):375-9. PubMed ID: 8880285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pranlukast allows reduction of inhaled steroid dose without deterioration in lung function in adult asthmatics].
    Tomita K; Hashimoto K; Matsumoto S; Nakamoto N; Tokuyasu H; Yamasaki A; Yajima H; Sasaki T; Kawasaki Y; Fukutani K
    Arerugi; 1999 Apr; 48(4):459-65. PubMed ID: 10355150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased exhaled nitric oxide in mild persistent asthma patients treated with a leukotriene receptor antagonist, pranlukast.
    Kobayashi H; Takahashi Y; Mitsufuji H; Hataishi R; Cui T; Tanaka N; Kawakami T; Tomita T
    Jpn J Physiol; 1999 Dec; 49(6):541-4. PubMed ID: 10603440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of theophylline or pranlukast, a cysteinyl leukotriene receptor 1 antagonist, as add-on therapy in uncontrolled asthmatic patients with a medium dose of inhaled corticosteroids.
    Tsuchida T; Matsuse H; Machida I; Kondo Y; Saeki S; Tomari S; Obase Y; Matsuo N; Shimoda T; Kohno S
    Allergy Asthma Proc; 2005; 26(4):287-91. PubMed ID: 16270722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of clarithromycin on the pharmacokinetics of pranlukast in healthy volunteers.
    Nakade S; Yamauchi A; Komaba J; Ohno T; Kitagawa J; Honda N; Hasegawa C; Yoneda K; Kodama Y; Yasuda K; Azuma J; Miyata Y
    Drug Metab Pharmacokinet; 2008; 23(6):428-33. PubMed ID: 19122337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence study of montelukast tablets in healthy Pakistani volunteers.
    Abbas M; Khan AM; Amin S; Riffat S; Ashraf M; Waheed N
    Pak J Pharm Sci; 2013 Mar; 26(2):255-9. PubMed ID: 23455193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pharmacokinetics and pharmacogenetics on the efficacy of pranlukast in Japanese asthmatics.
    Asano K; Nakade S; Shiomi T; Nakajima T; Suzuki Y; Fukunaga K; Oguma T; Sayama K; Fujita H; Tanigawara Y; Ishizaka A
    Respirology; 2009 Aug; 14(6):822-7. PubMed ID: 19703064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving dissolution and oral bioavailability of pranlukast hemihydrate by particle surface modification with surfactants and homogenization.
    Ha ES; Baek IH; Yoo JW; Jung Y; Kim MS
    Drug Des Devel Ther; 2015; 9():3257-66. PubMed ID: 26150699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of pranlukast hydrate dry syrup in children with allergic rhinitis and bronchial asthma.
    Nakade S; Ueda S; Ohno T; Nakayama K; Miyata Y; Yukawa E; Higuchi S
    Drug Metab Pharmacokinet; 2006 Apr; 21(2):133-9. PubMed ID: 16702733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of food intake on the pharmacokinetic properties of dalcetrapib: findings from three phase I, single-dose crossover studies in healthy volunteers.
    Derks M; Kawamura H; Abt M; Meneses-Lorente G; Phelan M; Ishikawa T
    Clin Ther; 2011 Jun; 33(6):754-65. PubMed ID: 21704240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of Solubility, Transport Across Madin-Darby Canine Kidney Monolayers and Oral Absorption of Pranlukast Through Preparation of a Pranlukast-Phospholipid Complex.
    Hao Y; Wang L; Li J; Liu N; Feng J; Zhao M; Zhang X
    J Biomed Nanotechnol; 2015 Mar; 11(3):469-77. PubMed ID: 26307829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhance the dissolution rate and oral bioavailability of pranlukast by preparing nanosuspensions with high-pressure homogenizing method.
    Wang L; Hao Y; Liu N; Ma M; Yin Z; Zhang X
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1381-9. PubMed ID: 22300415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical effects of long-term administration of pranlukast, a leukotriene receptor antagonist, on adult patients with bronchial asthma].
    Horiguchi T; Kondo R; Miyazaki J; Shiga M; Sugiyama M; Hirose M; Tachikawa S
    Nihon Kokyuki Gakkai Zasshi; 2003 Oct; 41(10):696-703. PubMed ID: 14584388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of add-on pranlukast in stable asthma; the additive effect on peripheral airway inflammation.
    Yasui H; Fujisawa T; Inui N; Kato M; Hashimoto D; Enomoto N; Nakamura Y; Shirai T; Suda T; Nakamura H; Chida K
    Respir Med; 2012 Apr; 106(4):508-14. PubMed ID: 22265857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.